First Affirmative Financial Network Has $300,000 Stake in Zoetis Inc. (NYSE:ZTS)

First Affirmative Financial Network lowered its position in Zoetis Inc. (NYSE:ZTS) by 7.6% during the first quarter, according to its most recent filing with the SEC. The firm owned 1,775 shares of the company’s stock after selling 146 shares during the period. First Affirmative Financial Network’s holdings in Zoetis were worth $300,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ZTS. Blue Bell Private Wealth Management LLC lifted its position in shares of Zoetis by 222.5% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after purchasing an additional 89 shares during the period. Independence Bank of Kentucky increased its stake in shares of Zoetis by 371.4% in the 4th quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock valued at $33,000 after acquiring an additional 130 shares in the last quarter. Private Wealth Management Group LLC bought a new stake in shares of Zoetis in the 4th quarter valued at $33,000. Ramirez Asset Management Inc. bought a new stake in shares of Zoetis in the 3rd quarter valued at $35,000. Finally, Gladius Capital Management LP bought a new stake in shares of Zoetis in the 4th quarter valued at $40,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Zoetis Price Performance

NYSE ZTS opened at $171.09 on Friday. The company has a market cap of $78.07 billion, a PE ratio of 32.97, a price-to-earnings-growth ratio of 2.61 and a beta of 0.88. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The company has a quick ratio of 1.94, a current ratio of 3.33 and a debt-to-equity ratio of 1.30. The firm’s 50-day simple moving average is $166.56 and its two-hundred day simple moving average is $179.20.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.34 by $0.04. The business had revenue of $2.19 billion for the quarter, compared to the consensus estimate of $2.14 billion. Zoetis had a net margin of 27.38% and a return on equity of 50.34%. The company’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 earnings per share. Research analysts predict that Zoetis Inc. will post 5.76 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 4th. Stockholders of record on Thursday, July 18th will be given a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s dividend payout ratio is presently 33.33%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Piper Sandler reiterated an “overweight” rating and issued a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. The Goldman Sachs Group cut their price objective on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a report on Monday, May 6th. Stifel Nicolaus cut their price objective on shares of Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Barclays cut their price objective on shares of Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 23rd. Finally, HSBC cut their price objective on shares of Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $211.75.

Insider Activity

In other news, EVP Roxanne Lagano sold 923 shares of the company’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $151.17, for a total transaction of $139,529.91. Following the sale, the executive vice president now directly owns 14,800 shares in the company, valued at $2,237,316. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.16% of the company’s stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.